JSPR earnings: a positive outcome, +12.4%

On August 13, 2024, Jasper Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +12.4% in the window around the event. It had already run -14.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.